260129 - Contract for Supply, Delivery and Installation of Peptide Synthesizer and associated Maintenance, training, Ancillary Items and Consumables

UK7Contract details notice093926-2026QBQueen's University Belfast
Estimated value—
Deadline—
Competition00 participants
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
Contract type
—
Deadline
—
CPV codes
37315100 - Synthesisers38000000 - Laboratory, optical and precision equipments (excl. glasses)
Status
Complete
Notice type
UK7Contract details notice
Estimated value
—
Publication date
5 Oct 2026, 14:23

Overview

Queen’s University Belfast - The Future Medicines Institute (FMI) intends to procure a peptide synthesis solution comprising equipment, associated consumables, and appropriate maintenance and support arrangements to enable in house peptide synthesis capability. • Establishment of a reliable, in house peptide synthesis capability aligned to research delivery requirements. • Provision of supplier support, including training, to ensure competent and effective operation by authorised users. • Delivery of scalable synthesis capability to support routine generation of short peptides and time efficient synthesis of longer peptide sequences. • Enablement of consistent, reproducible outputs to meet ongoing and future research needs. The Future Medicines Institute (FMI) is focused on the identification and development of novel therapeutics and diagnostic approaches. The required capability will support experimental workflows by enabling the generation of peptide materials essential to underpin these research activities, contributing to institutional strategic objectives in advanced therapeutics. The solution is expected to support broader academic use, enabling access across relevant research groups and maximising utilisation. This will facilitate collaborative research activity and enhance overall institutional research capability and impact.

Procurement Act 2023

Open procedure

Contracting authorities1

QB

NIC 101788

gbBelfast, United Kingdom
[email protected]

Lots1

Documentation0

Documents have not been synced yet. Last checked 24 Oct 2026, 16:10.

Award criteria0

No procedure-level award criteria recorded.

Participants1